Last edition
News about Global Pharma
Born from the amalgamation of six asset-centric Medicxi companies, Alys aims to revolutionize dermatological treatments with its innovative programs and platforms targeting various dermatological indications.
Global Pharma | 13/02/2024 | By Manvi | 1180
Aparna Organics Receives USFDA VAI Classification for Manufacturing Facility
Its manufacturing facility, Aparna Organics, located in Pydibhimavaram, Srikakulam, Andhra Pradesh, has been awarded the VAI classification by the USFDA.
Global Pharma | 13/02/2024 | By Manvi | 1223
Lykos Therapeutics Announces FDA Acceptance
The FDA has granted the application priority review and has assigned a Prescription Drug User Fee Act (PDUFA) target action date of August 11, 2024.
Global Pharma | 10/02/2024 | By Manvi | 721
Zynex Receives FDA Clearance for Next-Gen M-Wave Neuromuscular Stimulation Device
The M-Wave, successor to the renowned E-Wave, revolutionizes NMES treatments with enhanced functionality and a user-friendly design.
Global Pharma | 08/02/2024 | By Manvi | 1414
Sibel Health's ANNE One Receives 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring
This latest clearance expands the capabilities of the ANNE® One platform to include continuous ambulatory ECG monitoring, SpO2, temperature, and non-invasive blood pressure measurements.
Global Pharma | 08/02/2024 | By Manvi | 1142
Thermax Acquires TSA Process Equipments
Thermax has signed definitive agreements for acquisition to be completed in due course and will fully acquire the balance stake of the company over the next two years.
Global Pharma | 07/02/2024 | By Manvi | 861
AstraZeneca Invests USD 300 Million in Cutting-Edge Cell Therapy Facility in Rockville, MD
The site, strategically located within Maryland's flourishing life sciences corridor and near universities, underscores AstraZeneca's commitment to innovation and talent recruitment.
Global Pharma | 07/02/2024 | By Manvi | 460
Empower Pharma Acquires East Windsor Facility for Pharmaceutical Expansion
The companies anticipate completing the transaction in the coming months, subject to the satisfaction of closing conditions.
Global Pharma | 07/02/2024 | By Manvi | 616
The distribution agreement includes KRONOS products for Brenntag Specialties’ customers in Life Science segments, which include pharmaceutical as well as cosmetics and personal care applications.
Global Pharma | 06/02/2024 | By Manvi | 302
Zuellig Pharma Expands Healthcare Portfolio with Acquisition of Cialis and Alimta Brands
The acquisition covers Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, and Thailand through its wholly-owned subsidiary, Zanovex Pte. Ltd.
Global Pharma | 05/02/2024 | By Manvi | 1903
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy